Mr Karl D Handelsman

KANDO id: 23746

Bio

Karl has been privileged to work alongside talented entrepreneurs. The management teams at Ambrx, Ensemble Discovery, Ilypsa, Intellikine, Kalypsys, Maxygen, Phenomix, Rigel, Syrrx, Tetraphase, and Xenoport – all have contributed to Karl’s wealth of experience executing visionary plans. Prior to joining CMEA, Karl worked in biotech business development at Millennium. He was one of the first employees of Tularik, and the Whitehead Institute. Ensemble Discovery (Observer), Intellikine, Phenomix ( Observer), Tetraphase Graduate Degrees, MIT and Harvard Medical School

Education